ERBB2 and neoplasm: Treatment beyond surgery, chemotherapy, and radiotherapy is directed according to ER, PgR, and HER2 status, with endocrine therapy or trastuzumab available for patients with hormone receptor positive and HER2 positive tumours, respectively.